picotamide has been researched along with Myocardial Ischemia in 1 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neri Serneri, GG | 1 |
| Gensini, GF | 1 |
| Poggesi, L | 1 |
| Modesti, PA | 1 |
| Rostagno, C | 1 |
| Boddi, M | 1 |
| Gori, AM | 1 |
| Martini, F | 1 |
| Ieri, A | 1 |
| Margheri, M | 1 |
1 trial available for picotamide and Myocardial Ischemia
| Article | Year |
|---|---|
The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes.
Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Double-Blind Method; Female; Follow-Up Studies; Hu | 1994 |